(MENAFN - Newsfile Corp) ACMR Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ACM Research, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
New York, New York (Newsfile Corp. - February 19, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ACM Research, Inc. ( ACM or the Company ) (NASDAQ: ACMR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired ACM securities between March 6, 2019 - October 7, 2020, inclusive (the Class Period ). Such investors are encouraged to join this case by visiting the firm s site: .
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
#GMAIL: Want to get responses to your emails? Try some of these tips, from Boomerang, which could help you make the most of what you are trying to say in GMAIL. or in EMAIL!
#GMAIL: Want to get responses to your emails? Try some of these tips, from Boomerang, which could help you make the most of what you are trying to say in GMAIL. or in EMAIL!
#GMAIL: Want to get responses to your emails? Try some of these tips, from Boomerang, which could help you make the most of what you are trying to say in GMAIL. or in EMAIL!
Sheth) The behavioral tools of choice architecture, message framing, addressing cognitive biases, and creating norms can be powerful arsenals in the policy-makers tool kit to influence pro-vaccination behavior for the COVID-19 disease. Although widespread vaccinations can help address the COVID-19 pandemic in India, multiple barriers may limit vaccine uptake. In light of the country s goal of inoculating approximately 1.3 billion people within a year, this article applies insights from behavioural economics in the context of vaccination hesitancy and acceptance in India, focusing on strategies for bridging the intention-action gap. It also offers recommendations to policymakers and healthcare practitioners to help increase COVID-19 vaccination uptake.